WallStreetZenWallStreetZen

NASDAQ: KYMR
Kymera Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Kymera Therapeutics revenue was $51.48M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2026) ending on Mar 31, 2026 was $34.4M, up 1,097.4% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, KYMR annual revenue was $39.2M, with -16.7% growth year-over-year.

KYMR past revenue growth

How has KYMR's revenue growth performed historically?

Company
-12.58%
Industry
501.7%
Market
37.17%
KYMR's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
KYMR's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
KYMR's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

KYMR revenue history

Current Revenue
$51.5M
Current Earnings
-$315.0M
Current Profit Margin
-612%

Be the first to know when KYMR announces revenue.

KYMR Revenue History By Year

KYMR Yearly RevenueKYMR RevenueKYMR ChangeKYMR Revenue Growth
2025-12-31$39.21M-$7.86M-16.70%
2024-12-31$47.07M-$31.52M-40.11%
2023-12-31$78.59M$31.77M+67.84%
2022-12-31$46.83M-$26.01M-35.71%
2021-12-31$72.83M$38.80M+114.00%
2020-12-31$34.03M$31.10M+1,059.99%
2019-12-31$2.93MN/AN/A
2018-12-31$0.00N/AN/A

1 of 1

Kymera Therapeutics Revenue FAQ

What was KYMR's revenue last quarter?

On Invalid Date, Kymera Therapeutics (NASDAQ: KYMR) reported Q1 2026 revenue of $34.37 million up 55.5% year over year. In the same quarter last year, Kymera Therapeutics's revenue was $22.10 million.

What was Kymera Therapeutics's revenue in 2025?

Kymera Therapeutics's annual revenue for the twelve months ending Dec 31, 2025 was $39.21 million, a 16.7% decrease year over year.

How much does Kymera Therapeutics make in a day?

Based on Kymera Therapeutics annual revenue for the past five years, KYMR makes an average of $155,908.49 per day.

What was Kymera Therapeutics's annual revenue growth in the past year?

As of Q2 2026, Kymera Therapeutics's revenue has grown -12.58% year over year. This is 514.28 percentage points lower than the US Biotechnology industry revenue growth rate of 501.7%. Kymera Therapeutics's revenue in the past year totaled $51.48 million.

How much does Kymera Therapeutics make in a year?

Kymera Therapeutics's revenue by year for the past five years is:
  • Kymera Therapeutics's revenue for the twelve months ending Dec 31, 2025 was $39.21 million, a 16.7% decrease year over year.
  • Kymera Therapeutics's annual revenue for Dec 31, 2024 was $47.07 million, a 40.11% decrease from 2023.
  • Kymera Therapeutics's annual revenue for 2023 was $78.59 million, a 67.84% increase from 2022.
  • Kymera Therapeutics's annual revenue for 2022 was $46.83 million, a 35.71% decrease from 2021.
  • Kymera Therapeutics's annual revenue for 2021 was $72.83 million, a 114% increase from 2020.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.